Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody development
Annals of the Rheumatic Diseases · 2025-05 · 84 (5) · 789-797
DOI: 10.1016/j.ard.2025.01.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2025-05. Verfasst von Sehwan Chun und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Kyung Hee University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antibodies, Antinuclear. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
OBJECTIVES: This study aimed to investigate the association between the genetic burden of systemic lupus erythematosus (SLE) and the loss of tolerance to self-nuclear antigens in the preclinical stage. METHODS: We analysed genetic data from 349 Korean individuals who tested positive for autoantibodies in the preclinical stage, along with 33,596 healthy controls and 2057 patients with SLE. Genome-wide and pathway-specific polygenic risk scores (PRSs) of SLE were calculated based on 180 known non-human leukocyte antigen (non-HLA) SLE loci, HLA-DRB1 classical alleles, and predefined immune-related pathways to subsequently correlate with clinical phenotypes, particularly the presence of antinuclear antibodies (ANAs) at various titre thresholds. RESULTS: Individuals with preclinical autoimmune conditions exhibited significantly higher SLE PRSs than healthy controls (P = 2.99 × 10-5), with a significantly upward trend between ANA titres and PRS (P = 1.12 × 10-3). Stratification analysis revealed that preclinical-stage individuals with PRSs exceeding the means of age- and sex-matched PRSs among patients with SLE were at a significantly higher risk of ANA development (odds ratio = 2.25; P = 8.12 × 10-3 at a dilution factor of 1:80). Pathway-specific PRS analysis identified the significant enrichment of SLE-risk effects in nine pathways, such as signalling related to reactive oxygen species production, T cell receptor, B cell receptor, and cytokines, in ANA-positive preclinical individuals (Padjusted < 0.05). CONCLUSIONS: Our findings illustrate that the genetic burden of SLE may lead to a crucial transition from normal to preclinical autoimmune conditions prior to the pathogenic stage by increasing the susceptibility to and levels of ANAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, Kyung Hee University, Seoul, Republic of Korea.
- Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea; Hanyang Institute of Bioscience…
- Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea; Hanyang Institute of Bioscience and Biotechnology, Seoul, Republic of Korea.
- Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea; Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
- Department of Periodontology, Division of Dentistry, Hanyang University, College of Medicine, Seoul, Republic of Korea.
- Department of Biology, Kyung Hee University, Seoul, Republic of Korea; Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul, Republic of Korea. Electronic address: kkim@khu.ac.kr.
Förderung
- National Research Foundation of Korea
Zitieren
APA
Chun, S., Bang, S. Y., Kwon, A., Kim, C. Y., Cha, S., Kwon, Y. C., Joo, Y. B., Cho, S. K., Choi, C. B., Sung, Y. K., Han, J. Y., Kim, T. H., Jun, J. B., Yoo, D. H., Lee, H. S., Kim, K., & Bae, S. C. (2025). Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody development. Annals of the Rheumatic Diseases, 84(5), 789-797. https://doi.org/10.1016/j.ard.2025.01.015
Vancouver
Chun S, Bang SY, Kwon A, Kim CY, Cha S, Kwon YC, et al. Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody development. Annals of the Rheumatic Diseases. 2025;84(5):789-797. doi:10.1016/j.ard.2025.01.015
BibTeX
@article{Chun2025,
author = {Chun, Sehwan and Bang, So-Young and Kwon, Ayeong and Kim, Chan Young and Cha, Soojin and Kwon, Young-Chang and Joo, Young Bin and Cho, Soo-Kyung and Choi, Chan-Bum and Sung, Yoon-Kyoung and Han, Ji-Young and Kim, Tae-Hwan and Jun, Jae-Bum and Yoo, Dae Hyun and Lee, Hye-Soon and Kim, Kwangwoo and Bae, Sang-Cheol},
title = {Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody development},
journal = {Annals of the Rheumatic Diseases},
year = {2025},
volume = {84},
number = {5},
pages = {789--797},
doi = {10.1016/j.ard.2025.01.015}
}
EUVIMED